Sutro Biopharma
STRO
#9292
Rank
NZ$0.26 B
Marketcap
NZ$15.72
Share price
-1.38%
Change (1 day)
950.89%
Change (1 year)

Earnings for Sutro Biopharma (STRO)

Earnings in 2026 (TTM): -NZ$0.25 Billion

According to Sutro Biopharma's latest financial reports the company's current earnings are NZ$45.7 Million. In 2025 the company made an earning of -NZ$0.28 Billion, an increase over its 2024 earnings that were of -NZ$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sutro Biopharma from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.25 Billion-11.4%
2025 -NZ$0.28 Billion-21.54%
2024 -NZ$0.35 Billion193.07%
2023 -NZ$0.12 Billion-42.79%
2022 -NZ$0.21 Billion10.7%
2021 -NZ$0.19 Billion265.05%
2020 -NZ$51.28 Million-45.42%
2019 -NZ$93.95 Million48.65%
2018 -NZ$63.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.3 Billion 14.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$33.19 Million-86.95%๐Ÿ‡บ๐Ÿ‡ธ USA